Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Completed 5Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 4Gastrointestinal 4Thoracic 3Sarcoma 3Plasma cell 2Gynecologic 2Genitourinary 2Breast 2Other neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Dermatologic 1

Conditions

Ovarian Neoplasms 406Uterine Cervical Neoplasms 400Endometrial Neoplasms 197Carcinoma, Ovarian Epithelial 100Breast Neoplasms 72Fallopian Tube Neoplasms 71Uterine Cervical Dysplasia 68Neoplasms 51Colorectal Neoplasms 42Pancreatic Neoplasms 40Stomach Neoplasms 39Peritoneal Neoplasms 32Papillomavirus Infections 32Recurrence 31Uterine Neoplasms 29Vulvar Neoplasms 27Prostatic Neoplasms 26Lung Neoplasms 24Esophageal Neoplasms 23Urinary Bladder Neoplasms 22Melanoma 20Colonic Neoplasms 20Head and Neck Neoplasms 19Gynecologic Cancer 19Endometrial Hyperplasia 18Neoplasm Metastasis 17Carcinoma, Non-Small-Cell Lung 17Squamous Intraepithelial Lesions 16Sarcoma 16Ovarian Cysts 15

Interventions

Methotrexate 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Drug-Related Side Effects and Adverse Reactions × Gynecologic × Clear all
NCT04635956 2020-11-19

Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas

Peking Union Medical College Hospital

Phase 2 Unknown
20 enrolled
Gynecologic

Uterine Cervical Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT03885388 2019-03-21

Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma (GTN) Patients With Score of 5-6

Women's Hospital School Of Medicine Zhejiang University

Phase 2/3 Unknown
300 enrolled
Gynecologic

Gestational Trophoblastic Disease, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡